Welcome to our dedicated page for MSP Recovery SEC filings (Ticker: MSPR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MSP Recovery's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MSP Recovery's regulatory disclosures and financial reporting.
MSP Recovery, Inc. entered into a July 8, 2026 letter agreement with VRM MSP Recovery Partners, LLC under which VRM will provide a one-time $0.3 million advance to support certain operating expenses, consistent with an operating budget previously approved by VRM. The advance is described as a one-time accommodation and does not obligate VRM or its affiliates to provide future funding, with VRM expressly reserving all rights under existing transaction documents.
In connection with this additional advance, MSP Recovery and VRM agreed to amendments and supplements to their existing arrangements, including the Master Transaction Agreement and the Amended and Restated Security Agreement. The letter agreement states it is not intended to be a novation of existing obligations and does not change the priority of VRM’s existing liens except as expressly provided.
MSP Recovery, Inc. files a prospectus supplement to register the resale of 32,220 shares of Class A Common Stock.
The registration includes up to 15,239 shares issuable upon exercise of the CPIA Warrant at an exercise price of $0.4375 per share, which would produce only nominal proceeds to the company if exercised. The company effected a 1-for-7 reverse stock split effective September 1, 2025. Market quotes on July 7, 2026 showed the common stock at $0.0198, Public Warrants at $0.0045, and New Warrants at $0.0002. The company disclosed it remains delinquent in certain SEC reports and that OTC Markets will move its securities to the Expert Market effective on or around July 17, 2026.
MSP Recovery, Inc. files a prospectus supplement and Form 8-K registering 285,715 shares of Class A Common Stock for resale by Yorkville under a standby equity purchase agreement.
The filing describes the Yorkville SEPA (up to $250 million capacity), related Convertible Notes totaling $15.75 million originally, multiple subsequent advances, conversion mechanics with specified conversion prices and a 9.99% Ownership Limitation. The company notes its Class A common stock moved from Nasdaq to the OTCQB and that trading will be designated on the OTC Markets "Expert Market" effective July 17, 2026.
MSP Recovery, Inc. registered 56,896 shares of Class A Common Stock for resale by selling securityholders under Prospectus Supplement No. 53, including shares issuable on specified warrants and shares issued as consideration.
The supplement attaches a Form 8-K disclosing the Company is delinquent in its SEC filings and was notified by OTC Markets that its publicly traded securities will be moved to the Expert Market, effective on or around July 17, 2026, because the Company does not expect to regain current reporting status by the end of the grace period. The prospectus notes a 1-for-7 reverse stock split effective September 1, 2025, and states exercise prices on certain warrants are nominal ($0.0175), so proceeds on any exercises would be nominal.
MSP Recovery, Inc. files a prospectus supplement registering up to 909,982 shares of Class A Common Stock and up to 755,200,000 warrants, and noting up to 236,019 shares issuable upon exercise of warrants.
The supplement incorporates a Form 8-K disclosing the Company’s move to the OTC Markets Expert Market effective on or around July 17, 2026 due to delinquent SEC filings and confirms a 1-for-7 reverse stock split effective September 1, 2025.
MSP Recovery, Inc. reports that its Class A common stock and publicly traded warrants will be moved by OTC Markets Group from the OTC Pink Limited Information tier to the Expert Market on or around July 17, 2026. This change follows the company’s failure to file its Form 10-K for the period ending December 31, 2025 and Form 10-Q for the period ending March 31, 2026, leaving it non-current under SEC reporting rules and Rule 15c2-11 requirements for public quoting. On the Expert Market, broker-dealers may publish only unsolicited quotes, and quotations are primarily accessible to broker-dealers, institutions, and other sophisticated investors, which can significantly limit retail trading access and liquidity.
MSP Recovery, Inc. supplements its August 5, 2022 prospectus to register resale and warrant-related securities, listing up to 909,982 shares of Class A Common Stock, up to 755,200,000 warrants, and up to 236,019 shares issuable upon exercise of warrants.
The company also filed a Current Report disclosing a one-time Hazel Letter Agreement advance of $0.2 million funded June 26, 2026, under the discretionary Operational Collection Floor of its Working Capital Credit Facility. The prospectus notes a prior 1-for-7 reverse stock split effective September 1, 2025, and provides June 29, 2026 closing market prices for common stock and warrants.
MSP Recovery, Inc. files a prospectus supplement registering 285,715 shares of Class A Common Stock for offer and sale by the selling securityholder under its Form S-1 registration.
The supplement updates the prospectus with a Current Report on June 30, 2026 and describes the Yorkville SEPA, under which the company may issue and sell shares to YA II PN, Ltd. up to an aggregate contractual capacity of $250,000,000 (subject to ownership and exchange caps). The Yorkville arrangements include convertible notes and multiple amendments that set conversion mechanics, pricing floors, and historical Floor Price adjustments. The supplement notes that sales by Yorkville are resale transactions for which the company will not receive proceeds when Yorkville sells its shares; proceeds treatment for company-issued sales under the SEPA is described separately in the prospectus.
MSP Recovery, Inc. filed a Prospectus Supplement No. 63 updating its resale prospectus to cover the offer and sale of up to 32,220 shares of Class A Common Stock, including up to 15,239 shares issuable upon exercise of the CPIA Warrant at an exercise price of $0.4375 per share. The supplement attaches a Form 8-K describing a one-time $0.2 million advance from Hazel Partners Holdings, LLC under the Company’s discretionary Working Capital Credit Facility. The supplement notes closing market prices as of June 29, 2026 and that share counts reflect a 1-for-7 reverse stock split effective September 1, 2025.
MSP Recovery, Inc. amends its October 4, 2024 prospectus to register for resale 56,896 shares of Class A Common Stock. The supplement incorporates a Current Report on Form 8-K disclosing a one-time $0.2 million advance from Hazel Partners under the Company’s working capital facility and other selling‑holder details.
The registered shares include warrants issuable to Virage affiliates and shares issued to Palantir; the VRM and VRP warrants have a $0.0175 per‑share exercise price. Share and per‑share amounts reflect a 1-for-7 reverse stock split effective September 1, 2025.